IND Swift Laboratories

IND Swift Laboratories EBIT per Employee

The EBIT per Employee of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 17, 2026 is 106,257.35 INR. In the previous year, EBIT per Employee was 1.74 M INR — a change of -93.90% (lower).

EBIT per Employee

106,257.35INR

YoY

-93.90%

Last updated:

EBIT per Employee of IND Swift Laboratories is 2026 106,257.35 INR. EBIT per Employee of IND Swift Laboratories was 2025 1.74 M INR. It decreases by -93.90% lower compared to the previous year.

The IND Swift Laboratories EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
893,292.11 INR
Jan 1, 2020
488,810.16 INR
Jan 1, 2021
790,276.74 INR
Jan 1, 2022
617,800.80 INR
Jan 1, 2023
1.19 M INR
Jan 1, 2024
1.68 M INR
Jan 1, 2025
1.74 M INR
Jan 1, 2026
106,257.35 INR
The IND Swift Laboratories EBIT per Employee history
YEAREBIT per EmployeeYoY
106,257.35INR-93.90%
1.74 MINR+3.46%
1.68 MINR+41.03%
1.19 MINR+93.34%
617,800.80INR-21.82%
790,276.74INR+61.67%
488,810.16INR-45.28%
893,292.11INR+181.81%
316,980.61INR-181.26%
-390,099.60INR-31.66%
-570,800.80INR-40.97%
-967,040.11INR+0.44%
-962,811.83INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

EBIT per Employee of IND Swift Laboratories is 106,257.35 INR in 2026.

EBIT per Employee of IND Swift Laboratories changed from 1.74 M INR to 106,257.35 INR, representing a -93.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's IND Swift Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — IND Swift Laboratories

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — IND Swift Laboratories